1. 2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia.
- Author
-
Willows, Karla, Selk, Amanda, Auclair, Marie-Hélène, Jim, Brent, Jumah, Naana, Nation, Jill, Proctor, Lily, Iazzi, Melissa, and Bentley, James
- Subjects
- *
CERVICAL intraepithelial neoplasia , *COLPOSCOPY , *HEALTH facilities , *INFORMATION professionals , *GYNECOLOGIC oncology , *NURSE practitioners - Abstract
This guideline provides evidence-based guidance on the risk-based management of cervical dysplasia in the colposcopy setting in the context of primary HPV-based screening and HPV testing in colposcopy. Colposcopy management of special populations is also discussed. The guideline was developed by a working group in collaboration with the Gynecologic Oncology Society of Canada (GOC), Society of Colposcopists of Canada (SCC) and the Canadian Partnership Against Cancer (CPAC). The literature informing these guidelines was obtained through a systematic review of the relevant literature via a multi-step search process led by information specialists. The literature was reviewed up to June 2021 with manual searches of relevant national guidelines and more recent publications. Quality of the evidence and strength of recommendations was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. The intended users of this guideline include gynecologists, colposcopists, screening programs and healthcare facilities. Implementation of the recommendations is intended to promote equitable and standardized care for all people undergoing colposcopy in Canada. The risk-based approach aims to improve personalized care and reduce over-/under-treatment in colposcopy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF